Active	Status	Sponsor type	Region	Phase	Filter
3 Active 11 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kandioler, Daniela
NCT02140723: p53 and Response to Preoperative Radiotherapy for T2 and T3	Recruiting	2	60	Europe	preoperative short course radiation	Medical University of Vienna	Rectal Cancer	12/23	12/23
Lambers, Christopher
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype Nov 2023 - Dec 2023 : Acceptance of regulatory submission in China for chronic rhinosinusitis with nasal polyps	Recruiting	3	1700	Europe, Canada, Japan, US, RoW	GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)	GlaxoSmithKline, Iqvia Pty Ltd	Asthma	09/25	09/25
Gyoeri, Georg P
TRAILER, NCT04475887: Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation	Recruiting	4	60	Europe	Iron Carboxymaltose, IRON, Placebo	Medical University of Vienna	Liver Transplantation, Blood Loss	12/22	05/23